Tech Company Financing Transactions
Amplitude Vascular Systems Funding Round
On 1/28/2025, Amplitude Vascular Systems raised $36 million in Series B funding from private investors.
Transaction Overview
Company Name
Announced On
1/28/2025
Transaction Type
Venture Equity
Amount
$36,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to support the U.S. peripheral commercial launch as well as U.S. coronary and carotid IDE trials for its Pulse Intravascular Lithotripsy� (PIVL�) device.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
451 D Street 802
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Undisclosed
Website
Email Address
Overview
AVS is a medical device company focused on safely and effectively treating calcified arterial disease. Founded in 2017 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer, AVS is redefining interventional therapy for severely calcified lesions. And with our Pulse IVL� system, we're revolutionizing intravascular lithotripsy and transforming how physicians treat calcified arterial disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Mark Toland
Browse more venture capital transactions:
Prev: 1/28/2025: Atelerix venture capital transaction
Next: 1/28/2025: Lutris Pharma venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs